TABLE 3.
Human papillomavirus (HPV) vaccination coverage (≥3 dose) among male adolescents aged 13–17 years in the United States, by demographic and access-to-care characteristics--NIS-Teen 2013
| Unadjusted | Adjusted | |||
|---|---|---|---|---|
|
| ||||
| Vaccination coverage (≥3 dose) | Vaccination with ≥3 dose, Prevalence Ratio (PR) | Vaccination coverage (≥ 3 dose) | Vaccination with ≥3 dose, Prevalence Ratio (PR) | |
|
| ||||
| Characteristic | % (95% CI) | PR (95% CI) | % (95% CI) | PR (95% CI) |
| Total | 13.9 (12.5–15.3) | |||
| Age (years) | ||||
| 13–15* | 13.5 (11.8–15.5) | Ref | 13.3 (11.5–15.5) | Ref |
| 16–17 | 14.4 (12.3–16.7) | 1.06 (0.86–1.30) | 15.1 (12.4–18.2) | 1.13 (0.86–1.48) |
| Race/ethnicity | ||||
| Non-Hispanic White* | 11.1 (9.9–12.6) | Ref | 11.9 (10.4–13.5) | Ref |
| Non-Hispanic Black | 15.7 (12.3–19.9)† | 1.41 (1.08–1.85)† | 15.9 (12.3–20.4)† | 1.34 (1.01–1.77)† |
| Hispanic | 20.3 (16.2–25.1)† | 1.82 (1.41–2.34)† | 18.5 (14.8–22.8)† | 1.56 (1.19–2.04)† |
| American Indian/Alaskan Native | --‡ | --‡ | --‡ | --‡ |
| Asian | 9.1 (5.5–14.7) | 0.82 (0.49–1.36) | 7.7 (4.6–12.5) | 0.65 (0.39–1.08) |
| Other | 12.2 (8.6–16.8) | 1.09 (0.77–1.56) | 12.9 (9.2–17.7) | 1.08 (0.76–1.55) |
| Mother’s educational level | ||||
| <High School* | 20.9 (16.3–26.2) | Ref | 17.6 (13.4–22.8) | Ref |
| High School | 13.8 (10.7–17.5)† | 0.66 (0.47–0.93)† | 14.4 (11.3–18.1) | 0.81 (0.58–1.15) |
| Some college or college graduate | 11.1 (8.8–14.0)† | 0.53 (0.38–0.74)† | 12.3 (9.8–15.4) | 0.70 (0.48–1.01) |
| >College graduate | 13.2 (11.5–15.0)† | 0.63 (0.48–0.83)† | 13.3 (11.2–15.6) | 0.75 (0.53–1.06) |
| Mother’s married status | ||||
| Married* | 13.3 (11.7–15.1) | Ref | 13.8 (12.1–15.7) | Ref |
| Widowed/divorced/separated | 15.5 (12.4–19.2) | 1.16 (0.90–1.50) | 15.6 (12.5–19.4) | 1.13 (0.87–1.47) |
| Never married | 14.2 (10.8–18.4) | 1.06 (0.79–1.42) | 11.9 (8.8–15.8) | 0.86 (0.62–1.20) |
| Mother’s age | ||||
| ≤34 years* | 14.2 (10.7–18.7) | Ref | 13.7 (10.3–17.9) | Ref |
| 35–44 years | 12.6 (10.7–14.7) | 0.88 (0.64–1.22) | 12.5 (10.8–14.5) | 0.91 (0.67–1.24) |
| ≥45 years | 15.1 (13.0–17.4) | 1.06 (0.77–1.46) | 15.6 (13.3–18.3) | 1.14 (0.83–1.57) |
| Immigration status | ||||
| Born in U.S.* | 13.4 (12.1–14.9) | Ref | 13.6 (12.3–15.1) | Ref |
| Born outside U.S. | 22.2 (13.5–34.3) | 1.65 (1.02–2.68) | 21.7 (13.4–33.3) | 1.60 (1.00–2.56) |
| Income to poverty ratio | ||||
| <133%* | 17.5 (14.7–20.6) | Ref | 16.6 (13.1–20.8) | Ref |
| 133% – <322% | 11.1 (8.8–13.9)† | 0.64 (0.48–0.84)† | 12.1 (9.7–15.0) | 0.73 (0.51–1.03) |
| 322% – <503% | 10.2 (8.4–12.5)† | 0.59 (0.45–0.76)† | 10.7 (8.4–13.5)† | 0.64 (0.44–0.95)† |
| >503% | 15.1 (12.6–18.1) | 0.87 (0.68–1.11) | 14.9 (11.9–18.7) | 0.90 (0.61–1.32) |
| Medical insurance | ||||
| Private insurance only* | 13.2 (11.3–15.3) | Ref | 15.2 (12.4–18.4) | Ref |
| VFC Eligible-Medicaid/IHS/AIAN(All) | 15.3 (13.1–17.9) | 1.16 (0.94–1.44) | 14.0 (11.8–16.5) | 0.92 (0.69–1.23) |
| VFC Eligible-Uninsured | 6.3 (4.0–9.9)† | 0.48 (0.29–0.77)† | 5.5 (3.3–9.3)† | 0.37 (0.20–0.66)† |
| SCHIP(Public) | 19.6 (12.6–29.1) | 1.49 (0.95–2.32) | 19.2 (12.8–27.9) | 1.27 (0.82–1.96) |
| Military | 10.4 (6.4–16.4) | 0.79 (0.48–1.29) | 13.0 (7.8–20.8) | 0.85 (0.51–1.42) |
| Other | --‡ | --‡ | --‡ | --‡ |
| Physician contacts within past year | ||||
| None* | 10.9 (8.0–14.9) | Ref | 11.3 (8.6–14.7) | Ref |
| 1 | 13.9 (11.4–16.9) | 1.27 (0.88–1.84) | 14.1 (11.7–16.9) | 1.25 (0.90–1.72) |
| 2–3 | 15.4 (13.0–18.1) | 1.40 (0.98–2.01) | 15.4 (13.1–18.1) | 1.36 (1.00–1.85) |
| ≥4 | 14.0 (11.8–16.5) | 1.28 (0.89–1.83) | 13.8 (11.5–16.4) | 1.22 (0.88–1.67) |
| Well-child visit at age 11–12 years | ||||
| Yes | 16.8 (14.3–19.5)† | 2.50 (1.82–3.44)† | 17.0 (14.5–19.8)† | 2.18 (1.58–3.02)† |
| No* | 6.7 (5.1–8.8) | Ref | 7.8 (5.8–10.3) | Ref |
| Not Liciensed§ | 14.3 (11.9–17.1)† | 2.14 (1.53–2.98)† | 13.4 (10.4–17.0)† | 1.72 (1.16–2.54)† |
| Don’t know | 14.3 (11.3–17.9)† | 2.13 (1.48–3.06)† | 14.2 (11.3–17.8)† | 1.83 (1.28–2.60)† |
| Number of providers | ||||
| 1 | 14.5 (12.6–16.7) | 1.26 (0.97–1.63) | 14.5 (12.5–16.7) | 1.17 (0.87–1.57) |
| 2 | 14.3 (11.8–17.3) | 1.24 (0.93–1.66) | 14.3 (11.8–17.1) | 1.15 (0.86–1.54) |
| ≥3* | 11.6 (9.3–14.3) | Ref | 12.4 (9.7–15.7) | Ref |
| MSA | ||||
| Urban area | 16.9 (14.7–19.4)† | 2.13 (1.68–2.71)† | 16.2 (14.2–18.5)† | 1.62 (1.27–2.08)† |
| Suburban area | 13.0 (11.0–15.4)† | 1.64 (1.26–2.12)† | 13.1 (11.0–15.5)† | 1.31 (1.01–1.71)† |
| Rural area* | 8.0 (6.5–9.6) | Ref | 10.0 (8.0–12.4) | Ref |
| Region | ||||
| Northeast | 18.5 (15.9–21.3) | 1.27 (0.91–1.76) | 17.5 (14.9–20.4) | 1.29 (0.92–1.81) |
| Midwest | 11.7 (9.8–13.9) | 0.80 (0.57–1.13) | 13.3 (11.1–15.8) | 0.98 (0.71–1.34) |
| South | 12.6 (10.8–14.7) | 0.87 (0.62–1.21) | 13.0 (11.1–15.0) | 0.96 (0.71–1.30) |
| West* | 14.6 (10.8–19.4) | Ref | 13.6 (10.2–17.8) | Ref |
| Facility type | ||||
| All private facilities* | 14.6 (12.6–16.8) | Ref | 13.6 (11.7–15.8) | Ref |
| All public facilities | 12.2 (8.8–16.8) | 0.84 (0.59–1.20) | 12.5 (9.2–16.9) | 0.92 (0.65–1.31) |
| All hospital facilities | 15.7 (12.0–20.3) | 1.08 (0.80–1.46) | 15.8 (12.0–20.4) | 1.16 (0.86–1.56) |
| All STD/school/teen clinics or other facilities | --‡ | --‡ | --‡ | --‡ |
| Mixed|| | 13.6 (11.3–16.2) | 0.93 (0.74–1.17) | 16.4 (13.2–20.1) | 1.20 (0.92–1.56) |
| Other¶ | --‡ | --‡ | --‡ | --‡ |
*
Reference level.
†
p value < 0.05 by t test for comparisons within each variable with the indicated reference level.
‡
Estimate may not be reliable due to relative standard error >30% or sample size <30.
§
This indicated that the adolescents were ≥13 years of age when HPV vaccination was recommended in 2006.
||
Mixed indicates that the facility is identified to be in more than one of the facility categories such as private, public, hospital, STD/school/teen clinics.
¶
Includes military, WIC clinics, and pharmacies.